{"id":"https://openalex.org/W4361944979","doi":"https://doi.org/10.1158/1078-0432.c.6522959","title":"Data from Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303","display_name":"Data from Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361944979","doi":"https://doi.org/10.1158/1078-0432.c.6522959"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6522959","doi":"https://doi.org/10.1158/1078-0432.c.6522959","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6522959","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6522959","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063134810","display_name":"Amanda K. Psyrri","orcid":"https://orcid.org/0000-0002-4321-766X","observed_orcids":["https://orcid.org/0000-0002-4321-766X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Psyrri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044564476","display_name":"Ju\u2010Whei Lee","orcid":"https://orcid.org/0000-0003-2068-8511","observed_orcids":["https://orcid.org/0000-0003-2068-8511"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ju-Whei Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005822897","display_name":"Eirini Pectasides","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eirini Pectasides","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026898666","display_name":"Maria Vassilakopoulou","orcid":"https://orcid.org/0000-0002-3129-2259","observed_orcids":["https://orcid.org/0000-0002-3129-2259"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Vassilakopoulou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015216961","display_name":"Efstratios K. Kosmidis","orcid":"https://orcid.org/0000-0001-9496-4828","observed_orcids":["https://orcid.org/0000-0001-9496-4828"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Efstratios K. Kosmidis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023000705","display_name":"Barbara Ann Burtness","orcid":"https://orcid.org/0000-0003-4660-1859","observed_orcids":["https://orcid.org/0000-0003-4660-1859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara A. Burtness","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027326018","display_name":"David L. Rimm","orcid":"https://orcid.org/0000-0001-5820-4397","observed_orcids":["https://orcid.org/0000-0001-5820-4397"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David L. Rimm","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109561731","display_name":"Harold J. Wanebo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harold J. Wanebo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5034392417","display_name":"Arlene A. Forastiere","orcid":"https://orcid.org/0000-0003-2238-3682","observed_orcids":["https://orcid.org/0000-0003-2238-3682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arlene A. Forastiere","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.968999981880188},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9259999990463257},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.6790000200271606},{"id":"https://openalex.org/keywords/erk1-2","display_name":"ERK1/2","score":0.9120000004768372},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.8640000224113464},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.824999988079071},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.8790000081062317},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8610000014305115},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7839999794960022},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9679999947547913}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.7994145154953003},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6393436193466187},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6120187044143677},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5937031507492065},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.5753393769264221},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5061697363853455},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.48233768343925476},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.45733290910720825},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.4383583068847656},{"id":"https://openalex.org/C193270364","wikidata":"https://www.wikidata.org/wiki/Q17141925","display_name":"Tissue microarray","level":3,"score":0.42752718925476074},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4224627614021301},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.30765795707702637},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.22790050506591797},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.1983613669872284},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1697980761528015},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.08001908659934998},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6522959","doi":"https://doi.org/10.1158/1078-0432.c.6522959","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6522959","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6522959","doi":"https://doi.org/10.1158/1078-0432.c.6522959","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6522959","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2127265232","https://openalex.org/W2594966530","https://openalex.org/W2603935706","https://openalex.org/W2972614630","https://openalex.org/W2887433064","https://openalex.org/W3019785843","https://openalex.org/W2965618014","https://openalex.org/W2003659527","https://openalex.org/W2248909429","https://openalex.org/W2588971095"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"We":[2],"sought":[3],"to":[4,141,261,271],"evaluate":[5],"the":[6,20,41,64,126,164],"correlation":[7],"between":[8],"tissue":[9,68],"biomarker":[10,160,165],"expression":[11,99],"(using":[12],"standardized,":[13],"quantitative":[14,105],"immunofluorescence)":[15],"and":[16,33,58,73,96,119,129,144,184,206,219,245,256],"clinical":[17],"outcome":[18],"in":[19,40,163,248,259,264],"E2303":[21],"trial.":[22],"Experimental":[23],"Design:":[24],"Sixty-three":[25],"eligible":[26],"patients":[27,152],"with":[28,54,63,153,176,201,240],"operable":[29],"stage":[30,221],"III/IV":[31],"head":[32],"neck":[34],"squamous":[35],"cell":[36],"cancer":[37],"(HNSCC)":[38],"participated":[39],"Eastern":[42],"Cooperative":[43],"Oncology":[44],"Group":[45],"(ECOG)":[46],"2303":[47],"phase":[48],"II":[49],"trial":[50],"of":[51,150,232],"induction":[52],"chemotherapy":[53],"weekly":[55],"cetuximab,":[56],"paclitaxel,":[57],"carboplatin":[59],"followed":[60],"by":[61,125],"chemoradiation":[62,263],"same":[65],"regimen.":[66],"A":[67],"microarray":[69],"(TMA)":[70],"was":[71],"constructed":[72],"EGF":[74],"receptor":[75],"(EGFR),":[76],"ERK1/2,":[77],"Met,":[78],"Akt,":[79],"STAT3,":[80],"\u03b2-catenin,":[81],"E-cadherin,":[82],"EGFR":[83],"Variant":[84],"III,":[85],"insulin-like":[86],"growth":[87],"factor-1":[88],"receptor,":[89],"NF-\u03baB,":[90],"p53,":[91],"PI3Kp85,":[92],"PI3Kp110a,":[93],"PTEN,":[94],"NRAS,":[95],"pRb":[97],"protein":[98,106],"levels":[100,172],"were":[101,123,139,161,173,238],"assessed":[102],"using":[103,131],"automated":[104],"analysis":[107,227],"(AQUA).":[108],"For":[109],"each":[110],"dichotomized":[111],"biomarker,":[112],"overall":[113],"survival":[114,117,121],"(OS),":[115],"progression-free":[116],"(PFS),":[118],"event-free":[120],"(EFS)":[122],"estimated":[124],"Kaplan\u2013Meier":[127],"method":[128],"compared":[130],"log-rank":[132],"tests.":[133],"Multivariable":[134],"Cox":[135,194],"proportional":[136],"hazards":[137],"models":[138],"used":[140],"estimate":[142],"HRs":[143],"test":[145],"for":[146,213],"significance.":[147],"Results:":[148],"Forty-two":[149],"63":[151],"TMA":[154],"data":[155],"on":[156],"at":[157],"least":[158],"one":[159],"included":[162],"analysis.":[166,250],"Tumor":[167],"extracellular":[168],"signal\u2013regulated":[169],"kinase":[170],"(ERK)1/2":[171],"significantly":[174,199],"associated":[175,200,239],"PFS":[177,207,244],"[HR":[178,186],"(low/high),":[179,187],"3.29;":[180],"P":[181,189],"=":[182,190,204,209],"0.026]":[183],"OS":[185,202,242],"4.34;":[188],"0.008].":[191],"On":[192],"multivariable":[193,249],"regression":[195],"analysis,":[196],"ERK1/2":[197],"remained":[198],"(P":[203,208],"0.024)":[205],"0.022)":[210],"after":[211],"controlling":[212],"primary":[214],"site":[215],"(oropharynx":[216],"vs.":[217,223],"non-oropharynx)":[218],"disease":[220],"(III":[222],"IV),":[224],"respectively.":[225],"Clustering":[226],"revealed":[228],"that":[229],"clusters":[230],"indicative":[231],"activated":[233],"RAS/MAPK/ERK":[234,257],"and/or":[235,243],"PI3K/Akt":[236,255],"pathways":[237,258],"inferior":[241],"maintained":[246],"significance":[247],"Conclusions:":[251],"These":[252],"results":[253],"implicate":[254],"resistance":[260],"cetuximab-containing":[262],"HNSCC.":[265],"Large":[266],"prospective":[267],"studies":[268],"are":[269],"required":[270],"validate":[272],"these":[273],"results.":[274],"Clin":[275],"Cancer":[276],"Res;":[277],"20(11);":[278],"3023\u201332.":[279],"\u00a92014":[280],"AACR.":[281]},"counts_by_year":[],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2023-04-05T00:00:00"}